The Utility of TRBC1 Immunohistochemistry in the Evaluation of T-Cell Lymphomas
- PMID: 40693682
- DOI: 10.1097/PAS.0000000000002455
The Utility of TRBC1 Immunohistochemistry in the Evaluation of T-Cell Lymphomas
Abstract
T-cell receptor β chain constant region 1 (TRBC1) is a useful marker for the detection of clonal T-cell populations and has been used in flow cytometry, with limited data on its utility as an immunohistochemical marker. We evaluated TRBC1 by immunohistochemistry (IHC) in 42 CD3-positive, T-cell receptor alpha beta-positive T-cell lymphomas and compared their expression pattern to a control cohort of 35 reactive lymph nodes and tonsils. TRBC1 restriction was evident in 37/42 (88%) lymphomas but indeterminate in 5 cases, most of which were follicular helper T-cell lymphomas, angioimmunoblastic type/nodal T follicular helper cell lymphomas, angioimmunoblastic type (AITL). 34/35 (97%) control cases had ∼50% as much TRBC1 staining as CD3; however, one tonsil, while not TRBC1 restricted, had much less staining than CD3, which was confirmed by TRBC1 flow cytometry. TRBC1 IHC was helpful in demonstrating clonality in most T-cell lymphomas, including all cases lacking flow cytometric studies, and in 2 cases without definite molecular evidence of clonality. In differentiating T-cell lymphoma from reactive lymphoid tissue, it had a sensitivity of 88% and specificity of 97%. Thus, TRBC1 IHC is a useful, rapid, and inexpensive tool in the diagnosis of T-cell lymphomas.
Keywords: T-cell clonality; T-cell lymphomas; TRBC1.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Campo E, Jaffe ES, Cook JR, et al. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood. 2022;140:1229–1253.
-
- Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36:1720–1748.
-
- Board. WCoHTE. Haematolymphoid Tumors, 5th ed. International Agency for Research on Cancer; 2024;11.
-
- Horwitz SM, Ansell S, Ai WZ, et al. T-cell lymphomas, version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20:285–308.
-
- Thandra KC, Barsouk A, Saginala K, et al. Epidemiology of Non-Hodgkin’s lymphoma. Med Sci. 2021;9:5.
LinkOut - more resources
Full Text Sources